IP

Ian Peikon

Co-Founder & Co-Chief Executive Officer

Seattle, Washington

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $10,000,000.00

Skills

Molecular Biology
Neuroscience
Biotechnology
Start-ups
Biomedical Engineering
Electrophysiology
Fluorescence Microscopy
Confocal Microscopy
Genetics
Matlab
Cell Biology
C++
Computational Biology
Bioinformatics
Synthetic Biology
Protein Purification
Western Blotting
PCR
Emulsion PCR
Cell Culture

Education

Lists including Ian

AH
AL
AS
AD

Based in Seattle

494 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Cajal Neuroscience

Seed

Total Funding: $96M

Work Experience

CN
Cajal Neuroscience

2020

  • Co-Founder & Co-Chief Executive Officer

    2020

P
Plexium

2022

  • Board Member

    2022

LC
Lux Capital

2019

  • Venture Partner

    2019

VNV Bio

2018 - 2022

  • Co-Founder & SAB Member

    2018 - 2022

    non-viral gene therapy delivery systems - acquired by Aera Therapeutics

K
Kallyope

2015 - 2019

  • Co-Founder & Director, Platform Biology & Technology

    2015 - 2019

    I was part of the founding team of Kallyope and led the platform for new target discovery.